Change of circulating tumor cells before and after neoadjuvant chemotherapy in patients with primary breast cancer

被引：1
|
作者：
Horiguchi, J.
Takata, D.
Rokutanda, N.
Nagaoka, R.
Tokiniwa, H.
Tozuka, K.
Sato, A.
Kikuchi, M.
Oyama, T.
Takeyoshi, I.
机构：
[1] Gunam Univ Hosp, Gunma, Japan
[2] Gunma Univ Hosp, Gunma, Japan
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS12-P3-06-29
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-06-29
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Immunohistochemical phenotype of breast cancer before and after neoadjuvant chemotherapy
    Burkadze, G.
    Tsikhiseli, G.
    Khardzeishvili, O.
    Gudadze, M.
    Khomasuridze, T.
    Gachechiladze, M.
    Turashvili, G.
    VIRCHOWS ARCHIV, 2009, 455 : 180 - 180
  • [42] Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I-III Triple-Negative Breast Cancer
    Hall, Carolyn
    Karhade, Mandar
    Laubacher, Barbara
    Anderson, Amber
    Kuerer, Henry
    DeSynder, Sarah
    Lucci, Anthony
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S552 - S558
  • [43] CIRCULATING TUMOR CELLS (CTCS) IN PERIPHERAL BLOOD OF BREAST CANCER PATIENTS BEFORE AND AFTER ADJUVANT CHEMOTHERAPY THE GERMAN SUCCESS-TRIAL
    Rack, B.
    Schindlbeck, C.
    Schneeweiss, A.
    Hilfrich, J.
    Lorenz, R.
    Jueckstock, J.
    Beckmann, M.
    Pantel, K.
    Lichtenegger, W.
    Sommer, H.
    Friese, K.
    Janni, W.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4048 - 4049
  • [44] Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer
    G Fürstenberger
    R von Moos
    R Lucas
    B Thürlimann
    H-J Senn
    J Hamacher
    E-M Boneberg
    British Journal of Cancer, 2006, 94 : 524 - 531
  • [45] Prognostic Value of Receptor Change After Neoadjuvant Chemotherapy in Breast Cancer Patients
    Ozdemir, Ozlem
    Zengel, Baha
    Cavdar, Demet Kocatepe
    Yilmaz, Cengiz
    Durusoy, Raika
    EUROPEAN JOURNAL OF BREAST HEALTH, 2022, 18 (02) : 167 - 171
  • [46] Aneuploid Circulating Endothelial Cells with Prognostic Value in Locally Advanced Breast Cancer Patients After Neoadjuvant Chemotherapy
    Li, Minghui
    Liu, Yuelin
    Han, Xu
    Li, Tao
    Zhang, Zhizheng
    Xue, Ningyi
    Liang, Mengdi
    Ma, Ge
    Xia, Tiansong
    BREAST CANCER-TARGETS AND THERAPY, 2024, 16 : 761 - 768
  • [47] Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer
    Fürstenberger, G
    von Moos, R
    Lucas, R
    Thürlimann, B
    Senn, HJ
    Hamacher, J
    Boneberg, EM
    BRITISH JOURNAL OF CANCER, 2006, 94 (04) : 524 - 531
  • [48] Circulating tumour cells in patients with operable breast cancer who received neoadjuvant chemotherapy
    Horiguchi, J.
    Takata, D.
    Rokutanda, N.
    Nagaoka, R.
    Sato, A.
    Tokiniwa, H.
    Uchida, S.
    Ogino, M.
    Iino, Y.
    Takeyoshi, I.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S53 - S54
  • [49] Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy
    Sanchez-Margalet, Victor
    Barco-Sanchez, Antonio
    Vdarino-Garcia, Teresa
    Jimenez-Corteguna, Carlos
    Perez-Perez, Antonio
    Henao-Cartusco, Fernando
    Virizuela-Echaburu, Juan A.
    Nogales-Fernandez, Esteban
    Alamo-de la Gala, Maria C.
    Lobo-Acosta, Maria A.
    Palazon-Carrion, Natalia
    Nieto, Adoracion
    de la Cruz-Merino, Luis
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (01) : 59 - 65
  • [50] The prognostic role of circulating tumor DNA after neoadjuvant chemotherapy in triple negative breast cancer with residual tumor
    Roseshter, Talia
    Klemantovich, Anna
    Cavallone, Luca
    Aguilar-Mahecha, Adriana
    Lafleur, Josiane
    Elebute, Oluwadara O.
    Jenna, Sarah
    Boileau, Jean-Francois
    Pelmus, Manuela
    Basik, Mark
    Lan, Cathy
    CANCER RESEARCH, 2023, 83 (05)
12345